Radovich Peter 4
4 · Mirum Pharmaceuticals, Inc. · Filed Jan 30, 2026
Research Summary
AI-generated summary of this filing
Mirum (MIRM) President & COO Peter Radovich Receives Equity Awards
What Happened Peter Radovich, President and Chief Operating Officer of Mirum Pharmaceuticals (MIRM), was granted three equity awards on January 28, 2026 totaling 75,900 derivative units (25,120 + 16,280 + 34,500). Each award was reported as acquired at $0.00 per unit (these are equity grants, not open‑market purchases or sales). The awards are restricted stock units (RSUs) and performance RSUs (PSUs) that convert to common shares upon vesting; no cash changed hands at grant.
Key Details
- Transaction date: January 28, 2026; Form 4 filed January 30, 2026 (timely filing).
- Consideration: $0.00 per unit (derivative awards, not purchases).
- Total units granted: 75,900 RSUs/PSUs.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Vesting/footnotes:
- One award vests 25% one year after Jan 28, 2026, then monthly over the next 36 months.
- One award vests 1/3 on each anniversary of Jan 28, 2026 (fully vested after 3 years).
- A PSU award (granted Jan 23, 2024) had performance criteria met on Jan 28, 2026; that award vests 2/3 on Mar 15, 2026 and 1/3 on Mar 15, 2027.
- These entries are coded as "A" (award/grant) and are derivative (convert to shares upon vesting).
Context These grants are executive compensation—common for senior management—and represent future contingent rights to Mirum common stock if vesting conditions are met. Because no shares were bought or sold and no cash was exchanged at grant, the awards do not indicate an immediate market purchase or sale by the insider. The filing appears timely (filed two days after the grant date).
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-01-28+25,120→ 25,120 totalExercise: $100.85Exp: 2036-01-27→ Common Stock (25,120 underlying) - Award
Restricted Stock Units
[F2][F3]2026-01-28+16,280→ 16,280 total→ Common Stock (16,280 underlying) - Award
Performance Restricted Stock Units
[F2][F4]2026-01-28+34,500→ 34,500 total→ Common Stock (34,500 underlying)
Footnotes (4)
- [F1]1/4th of the shares vest one year after January 28, 2026 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 28, 2026 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date.
- [F4]On January 23, 2024, the reporting person was granted performance restricted stock units ("PSUs") which vest upon satisfaction of certain performance criteria. On January 28, 2026, performance criteria were determined to have been met. The shares subject to the PSUs vest as follows: 2/3 of the shares vest on March 15, 2026 and 1/3 of the shares vest on March 15, 2027.